Significance of Alpha-Fetoprotein Mrna Level in Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation.

Xi-Lin Du,Qing-Jiu Ma,Tao Wu,Guo-Qiang Bao,Jian-Guo Lu,Yan-Kui Chu
2007-01-01
Abstract:BACKGROUND: Many methods are used to treat liver cancer. Among them, radiofrequency ablation (RFA) is a hot topic because of its advantages. This study was designed to determine the significance of blood alpha-fetoprotein mRNA (AFPmRNA) changes in patients with hepatocellular carcinoma (HCC) treated with RFA.METHODS: The AFPmRNA content in blood samples from HCC patients was determined by reverse transcriptase-polymerase chain reaction (RT-PCR) before RFA and 48 hours, 72 hours, I week and 2 weeks later.RESULTS: The blood of 183 patients was negative for AFPmRNA before REA, but that of 62 of them was positive 72 hours later, then returned to negative after 2 weeks. The blood of 129 patients was positive for AFPmRNA before RFA, but that of 112 of them became negative 2 weeks later; 17 patients were still AFPmRNA positive 2 weeks after REA.CONCLUSIONS: Blood AFPmRNA, which is increased temporarily after RFA, can be used as an objective index for the persistence and recurrence of HCC after REA.
What problem does this paper attempt to address?